95 related articles for article (PubMed ID: 25453800)
21. Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development.
De Simone R; Andrés RM; Aquino M; Bruno I; Guerrero MD; Terencio MC; Paya M; Riccio R
Chem Biol Drug Des; 2010 Jul; 76(1):17-24. PubMed ID: 20492447
[TBL] [Abstract][Full Text] [Related]
22. Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1.
Kapoor M; Mineau F; Fahmi H; Pelletier JP; Martel-Pelletier J
J Rheumatol; 2012 Mar; 39(3):635-44. PubMed ID: 22089456
[TBL] [Abstract][Full Text] [Related]
23. [Effect of luteolin on COX-2 and mPGES-1 expression in LPS-induced RAW264.7 cells].
Wang XG; Chen GY; Chen MP
Zhong Yao Cai; 2007 Oct; 30(10):1263-6. PubMed ID: 18300499
[TBL] [Abstract][Full Text] [Related]
24. Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen.
He S; Li C; Liu Y; Lai L
J Med Chem; 2013 Apr; 56(8):3296-309. PubMed ID: 23527738
[TBL] [Abstract][Full Text] [Related]
25. Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 production.
Lim C; Lee M; Park EJ; Cho R; Park HJ; Lee SJ; Cho H; Lee SK; Kim S
Bioorg Med Chem Lett; 2010 Dec; 20(23):6938-41. PubMed ID: 20970329
[TBL] [Abstract][Full Text] [Related]
26. Novel benzoxazole inhibitors of mPGES-1.
Kablaoui N; Patel S; Shao J; Demian D; Hoffmaster K; Berlioz F; Vazquez ML; Moore WM; Nugent RA
Bioorg Med Chem Lett; 2013 Feb; 23(3):907-11. PubMed ID: 23266122
[TBL] [Abstract][Full Text] [Related]
27. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2000 Jun; 272(3):744-8. PubMed ID: 10860826
[TBL] [Abstract][Full Text] [Related]
29. Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase.
Greco A; Ajmone-Cat MA; Nicolini A; Sciulli MG; Minghetti L
J Neurosci Res; 2003 Mar; 71(6):844-52. PubMed ID: 12605411
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of salidroside on nitric oxide and prostaglandin E₂ production in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Song B; Huang G; Xiong Y; Liu J; Xu L; Wang Z; Li G; Lu J; Guan S
J Med Food; 2013 Nov; 16(11):997-1003. PubMed ID: 24180550
[TBL] [Abstract][Full Text] [Related]
31. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages.
Díaz-Muñoz MD; Osma-García IC; Fresno M; Iñiguez MA
Biochem J; 2012 Apr; 443(2):451-61. PubMed ID: 22268508
[TBL] [Abstract][Full Text] [Related]
32. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
33. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.
Arhancet GB; Walker DP; Metz S; Fobian YM; Heasley SE; Carter JS; Springer JR; Jones DE; Hayes MJ; Shaffer AF; Jerome GM; Baratta MT; Zweifel B; Moore WM; Masferrer JL; Vazquez ML
Bioorg Med Chem Lett; 2013 Feb; 23(4):1114-9. PubMed ID: 23260349
[TBL] [Abstract][Full Text] [Related]
34. Development of a high-affinity inhibitor of the prostaglandin transporter.
Chi Y; Min J; Jasmin JF; Lisanti MP; Chang YT; Schuster VL
J Pharmacol Exp Ther; 2011 Nov; 339(2):633-41. PubMed ID: 21849625
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 1,5-diarylhaloimidazole analogs and their inhibitory activities against PGE₂ production from LPS-treated RAW 264.7 cells.
Yang Z; Truong TN; Pham TA; Lee JW; Kim SS; Park H
Bioorg Med Chem; 2012 Nov; 20(21):6256-9. PubMed ID: 23040893
[TBL] [Abstract][Full Text] [Related]
36. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.
Ikeda-Matsuo Y; Ikegaya Y; Matsuki N; Uematsu S; Akira S; Sasaki Y
J Neurochem; 2005 Sep; 94(6):1546-58. PubMed ID: 16000148
[TBL] [Abstract][Full Text] [Related]
37. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
[TBL] [Abstract][Full Text] [Related]
38. Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E(2) biosynthesis in vascular smooth muscle cells.
Camacho M; Gerbolés E; Escudero JR; Antón R; García-Moll X; Vila L
J Thromb Haemost; 2007 Jul; 5(7):1411-9. PubMed ID: 17403097
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors.
Dadashpour S; Tuylu Kucukkilinc T; Unsal Tan O; Ozadali K; Irannejad H; Emami S
Arch Pharm (Weinheim); 2015 Mar; 348(3):179-87. PubMed ID: 25690564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
